Symptomatik

DAST-10 (Drug Abuse Screening Test): Take It, Score It, Understand Your Results

The DAST-10 (Drug Abuse Screening Test, 10-item version) is a brief self-report screening tool that measures problems related to non-medical drug use over the past 12 months. Developed by Dr. Harvey Skinner at the Addiction Research Foundation in 1982 (as the longer DAST-28) and later shortened to the 10-item version, it is widely used in primary care, behavioral health, and substance-use research. The DAST-10 takes about 2 minutes to complete, is freely available, and produces a 0-10 score that helps a clinician decide whether brief intervention or further evaluation is warranted. The DAST-10 is a screening tool, not a diagnosis of substance use disorder.

How to score and interpret your results

The DAST-10 produces a total score from 0 to 10 — one point for each Yes answer, with item 3 reverse-scored (No earns the point). A score of 3 or higher is the most commonly cited threshold for a positive screen, meaning the result warrants further clinical conversation rather than constituting a diagnosis.

The bands below reflect the convention used on most public clinical handouts. They are not specified in Skinner’s original 1982 paper, and individual programs may use slightly different cutoffs depending on the setting (primary care, emergency department, or behavioral health intake).

Commonly cited DAST-10 cutoff bands

ScoreRisk levelTypical suggested action
0No problems reportedNo action needed beyond routine re-screening
1-2Low levelMonitor; re-assess at a later visit
3-5Moderate levelFurther investigation by a clinician
6-8Substantial levelIntensive assessment and treatment
9-10Severe levelIntensive assessment and treatment

What the score does — and does not — tell you

A DAST-10 score is a signal, not a label. The instrument was designed to flag drug-use patterns causing functional or health problems, so the score sums consequences (guilt, family complaints, withdrawal, medical problems) rather than substances or quantities used. A score in the moderate-or-higher range means a clinician should look more closely; it does not mean a substance use disorder has been diagnosed. That distinction matters because the U.S. Preventive Services Task Force explicitly names “stigma, labeling, or medicolegal consequences” as potential harms of drug screening when results are mishandled.

The score is also only as accurate as the answers behind it. The DAST-10 is a self-report instrument and is sensitive to recall and disclosure — both of which improve when the person taking it understands the goal is help, not judgment.

The 10 areas the DAST-10 covers

The DAST-10 asks ten yes/no questions about consequences of drug use over the past 12 months. The instrument focuses on drugs other than alcohol or tobacco, including illegal drugs and prescription medications taken in ways other than as prescribed. The verbatim item wording is copyrighted by the developer and the Addiction Research Foundation; the list below paraphrases each item rather than reproducing it.

Why these ten?

The 10-item form was condensed from the 28-item DAST published in 1982. The original instrument had an internal-consistency reliability of 0.92 and factor-analyzed as a single underlying dimension — meaning the items moved together statistically and could be summed into one meaningful total. The short form retained the items best preserving that single-factor structure, which is why the DAST-10 can be administered in about two minutes without losing core measurement quality.

What the items do not ask about

The DAST-10 does not ask about specific substances, quantities, frequencies, or routes of administration. It also does not ask about alcohol or tobacco — for alcohol screening, the World Health Organization’s AUDIT questionnaire is the standard parallel instrument. Medications taken exactly as prescribed are not counted as drug use under the DAST-10 framework.

What a positive screen means — and what it doesn’t

A “positive screen” on the DAST-10 (most commonly a score of 3 or higher) means the questionnaire has detected a pattern warranting closer clinical attention. It does not mean the person has a substance use disorder. That diagnosis is a clinical determination made by a qualified clinician evaluating the person against the DSM-5 criteria for substance use disorder.

MedlinePlus describes substance use disorder as a “chronic brain disease” that is relapsing in nature, and notes that not everyone who uses drugs develops the disorder — outcomes depend on genetic, environmental, and developmental factors. A screening instrument like the DAST-10 cannot capture that complexity in ten yes/no items. What it can do is start the conversation.

What “positive screen” triggers clinically

The USPSTF recommends drug screening (Grade B) for adults 18 and older — with a critical caveat: only when “services for accurate diagnosis, effective treatment, and appropriate care can be offered or referred”. A positive screen is meant to be the start of a process that includes brief intervention, further evaluation, and referral. It is not meant to stand alone, and it is not meant to be punitive.

False positives and false negatives

Like any brief self-report tool, the DAST-10 can both over-call and under-call. A person who answers honestly about transient or context-bound consequences may score above the cutoff without meeting criteria for a disorder; a person who minimizes (consciously or not) may score below the cutoff while still having significant problems. Skinner’s original validation noted the instrument’s correlation with social-desirability and denial response biases was only moderate — but not zero, which is the technical way of saying self-report screens are useful, not infallible.

How accurate is the DAST-10?

The strongest published psychometric data anchor to Skinner’s 1982 development paper for the 28-item parent instrument. In that study (256 drug or alcohol clients in clinical or help-seeking populations) the DAST had an internal-consistency reliability of 0.92 — described as “substantial” — and factor analysis indicated a single underlying dimension. The 10-item form was derived from this parent instrument with the goal of preserving its psychometric structure while shortening administration time.

What the psychometric terms mean

Internal consistency (Cronbach’s alpha) measures how well items in a scale move together — whether a person who endorses one item tends to endorse others tapping the same underlying issue. An alpha of 0.92 is high; it justifies summing the items into a single meaningful total. Unidimensional means the items load onto one factor rather than several, which justifies treating the total score as a meaningful summary rather than a mix of separate sub-scores.

The screening-tool tradeoff

Brief screening instruments are deliberately tuned to be sensitive — designed to rule in people who need a longer conversation, even at the cost of some false positives. Skinner himself noted in the original paper that further validation work was needed in other populations and settings beyond the help-seeking sample. We have intentionally not quoted a single sensitivity or specificity figure on this page because reported values vary widely with the cutoff used, the reference standard, and the population sampled. What is consistent is the principle: a positive DAST-10 should always be paired with a clinical conversation, not interpreted in isolation.

Limitations and considerations

The DAST-10 is brief, free, and widely used for its intended purpose — but it is not a complete picture of drug use. Knowing the limitations helps you interpret your score honestly.

What to do with your results and when to seek help

A DAST-10 score is most useful when it leads to action. The right action depends on the band your score falls into.

Some situations warrant a clinician conversation regardless of total score:

Bringing the score to a clinician

You do not need to justify your answers in advance. A useful approach is to bring the numerical score and the date you completed it, and say something like, “I took the DAST-10 and scored X. I would like to talk about what that means.” Clinicians familiar with the instrument can place the score in context and recommend next steps that may include brief intervention, further assessment, or referral to specialty care.

Treatment options exist

The National Institute on Drug Abuse describes substance use disorders as “chronic, treatable disorders that affect a person’s brain and behaviors, but from which people can recover”. NIDA outlines five primary treatment settings: outpatient care, intensive outpatient care, inpatient care, residential care programs, and opioid treatment programs. For opioid use disorder specifically, three FDA-approved medications are available — methadone, buprenorphine, and naltrexone — typically used alongside counseling and behavioral therapies. Medications are also approved for alcohol use disorder and tobacco dependence. Specific medication choices are decisions for a treating clinician.

Free, confidential help — two federal lines

To find specific treatment programs in your area, FindTreatment.gov is the SAMHSA-operated locator referenced by both NIDA and MedlinePlus. Person-first language is appropriate throughout — “person with substance use disorder” rather than older stigmatizing terms — reflecting the chronic-disease framing that current federal health agencies use.

Frequently asked questions

What kind of test is the DAST-10?

The DAST-10 is a screening instrument — a brief self-report questionnaire used to detect patterns of drug-related problems that warrant further evaluation. It is not a diagnostic test. A positive screen indicates a clinical conversation is warranted, not that a diagnosis has been made.

Is there a free DAST-10 PDF I can use?

The DAST-10 is freely available and widely distributed by NIDA, USPSTF resources, and state health agencies. The NIDA screening-tools chart notes that for formal use of the instrument, providers should contact the developer. The 10-item form takes about two minutes to complete on paper or on a screen.

How is the DAST-10 different from the AUDIT?

The DAST-10 covers drugs other than alcohol and tobacco; the AUDIT (Alcohol Use Disorders Identification Test) is the World Health Organization’s parallel instrument for alcohol use. Clinicians who want to screen for both often pair them, or use combined instruments such as ASSIST or TAPS named alongside the DAST-10 in the USPSTF recommendation. For the alcohol screen, see our AUDIT page.

Can I take the DAST-10 online?

Yes. The DAST-10 is a self-report instrument and can be completed on paper, on a screen, or with a clinician. The NIDA screening-tools chart lists both self-administered and clinician-administered formats. Honest answers about the past 12 months matter much more than the format you use to complete it.

Does a high DAST-10 score mean I have a drug addiction?

No. A high DAST-10 score is a positive screen — it indicates a clinical assessment is warranted. A diagnosis of substance use disorder is a clinical determination made by a qualified clinician using DSM-5 criteria, a substantially deeper evaluation than ten yes/no questions can provide. Two people with the same DAST-10 score can have very different clinical pictures.

What is the cutoff score on the DAST-10?

A score of 3 or higher is the most commonly cited threshold for a positive screen and a prompt to seek further clinical assessment. Bands typically continue at 1-2 (low), 3-5 (moderate), 6-8 (substantial), and 9-10 (severe). These cutoffs are not specified in the original Skinner 1982 paper — they reflect clinical-handout convention and may vary by setting.

Is there a DAST-10 for teenagers?

The DAST-10 itself is intended for adults. The adolescent version is called the DAST-20 in the NIDA screening-tools chart (the literature also uses “DAST-A” interchangeably). The USPSTF gives drug screening in adolescents (ages 12-17) a Grade I, meaning current evidence is insufficient to assess the balance of benefits and harms. Screening decisions for teenagers should be made with a clinician who knows the adolescent and the setting.